Scientific work

Prof. Dr. Çağlayan Geredeli

121 publications. The source of the information is stated next to each publication.

Back to profile
  1. Prognostic Significance of Mean Platelet Volume on Local Advanced Non-Small Cell Lung Cancer Managed with Chemoradiotherapy

    Scientific Reports, 2019

    DOI 10.1038/s41598-019-40589-4 PMID 30850724 16 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer

    Pulmonology, 2019

    DOI 10.1016/j.pulmoe.2019.11.007 PMID 31839507 14 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study

    Oncology Research and Treatment, 2019

    DOI 10.1159/000502120 PMID 31437835 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. The effects of diabetes and fasting plasma glucose on treatment of breast cancer with neoadjuvant chemotherapy

    Current Problems in Cancer, 2019

    DOI 10.1016/j.currproblcancer.2019.05.007 PMID 31200961 12 citations (Europe PMC) Source: OpenAlex

  5. The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer

    Journal of Cancer Research and Therapeutics, 2019

    DOI 10.4103/jcrt.jcrt_326_18 PMID 33380674 12 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Effect of Pretreatment Platelet Parameters on Survival in Limited Disease Small Cell Lung Cancer

    Asian Pacific Journal of Cancer Prevention, 2019

    DOI 10.31557/apjcp.2019.20.6.1879 PMID 31244313 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Factors affecting survival and treatment efficacy in breast cancer patients with bone marrow metastasis

    The Breast Journal, 2019

    DOI 10.1111/tbj.13647 PMID 31562662 10 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. Prognostic impact of blood transfusion in patients with metastatic non-small cell lung cancer receiving chemotherapy

    Lung Cancer, 2019

    DOI 10.1016/j.lungcan.2019.05.007 PMID 31200825 4 citations (Europe PMC) Source: OpenAlex

  9. Factors Affecting Disease-Free Survival in Operated Nonmetastatic Gastrointestinal Stromal Tumors

    Journal of Surgical Research, 2019

    DOI 10.1016/j.jss.2019.03.059 PMID 31026795 4 citations (Europe PMC) Source: OpenAlex

  10. Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis.

    PubMed, 2019

    PMID 31786840 5 citations (Europe PMC) Source: OpenAlex

  11. The evaluation of efficacy and tolerability of gemcitabine vs. capecitabine therapy in the second-line setting for metastatic pancreatic cancer patients with poor performance status

    Journal of Oncological Sciences, 2019

    DOI 10.1016/j.jons.2019.08.003 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  12. Efficacy and tolerability of adjuvant therapy in ≥70-year-old patients with T3N0M0 colorectal cancer: An observational study

    Journal of Oncology Pharmacy Practice, 2019

    DOI 10.1177/1078155219865008 PMID 31366267 3 citations (Europe PMC) Source: OpenAlex

  13. The effects of fulvestrant treatment on hormone receptor-positive metastatic breast cancer

    The European Research Journal, 2019

    DOI 10.18621/eurj.470881 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  14. Non-urothelial Bladder Cancers: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.galenos.2019.21931 Open-access full textSource: OpenAlex

  15. Adrenocortical Carcinoma: Single Center Experience

    European Archives of Medical Research, 2019

    DOI 10.4274/eamr.25744 Open-access full textSource: OpenAlex

  16. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.

    PubMed, 2019

    PMID 31786850 1 citation (Europe PMC) Source: OpenAlex

  17. Factors Affecting Survival in Neuroendocrine Tumors: A 15-Year Single Center Experience

    Asian Pacific Journal of Cancer Prevention, 2018

    DOI 10.31557/apjcp.2018.19.12.3597 PMID 30583688 9 citations (Europe PMC) Open-access full textSource: OpenAlex

  18. Prognostic significance of primary tumor localization in stage II and III colon cancer

    World Journal of Gastrointestinal Oncology, 2018

    DOI 10.4251/wjgo.v10.i11.410 PMID 30487952 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  19. Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease

    The Medical Journal of Okmeydani Training and Research Hospital, 2018

    DOI 10.5222/otd.2018.71224 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  20. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/jcrt.jcrt_911_17 PMID 32930124 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  21. Fulvestrant efficacy in artificial menopausal hormone receptor positive and HER 2 negative metastatic breast cancer patients under 50 years old.

    Journal of Clinical Oncology, 2018

    DOI 10.1200/jco.2018.36.15_suppl.e13000 Source: OpenAlex

  22. Opere erken evre kolon kanserinde vücut kitle indeksinin nüks lokalizasyonu, hastalıksız sağkalım ve genel sağkalım etkisi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  23. Erken evre(1-3) kolon kanseri hastalarında tümör lokalizasyonunun hastalıksı sağkalım ve genel sağkalıma etkisi:tek merkez deneyimi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  24. Hormon pozitif metastatik meme kanseri tedavisinde Fulvestrant etkinlik ve tolerabilitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  25. The Relationship Between Pathological Complete Response and Ki 67 İndex in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy: Retrospective Single Center Experience

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  26. Pleomorfik Sarkom tanılı hastada ifosfamid toksisitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  27. Opere iyi diferansiye Gastroenteropankreatik nöroendokrin tümörlerde Lenf nodu tutulumunun ve primer tümör lokalizasyonunun Klinik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  28. Metastatik mide kanserinde tanı anındaki PET-CT SUV-Max değerinin prognostik önemi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  29. Nüks Apendiks Adenokarsinoid Tümörü:Olgu Sunumu ve Literatür Güncellemesi

    Van Yüzüncü Yıl University Academic Data Management System, 2018

    Source: OpenAlex

  30. P3.01-33 EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis

    Journal of Thoracic Oncology, 2018

    DOI 10.1016/j.jtho.2018.08.1593 Open-access full textSource: OpenAlex

  31. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

    Journal of Cancer Research and Therapeutics, 2018

    DOI 10.4103/0973-1482.176417 PMID 29893321 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  32. FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer

    World Journal of Surgical Oncology, 2018

    DOI 10.1186/s12957-018-1359-9 PMID 29587749 4 citations (Europe PMC) Open-access full textSource: ORCID

  33. Folfiri plus panitumumab as the first-line treatment in patients with RAS wild-type metastatic colorectal cencer. A single center experience.

    The Medical Journal of Okmeydani Training and Research Hospital, 2018

    DOI 10.5222/otd.2018.70431 Open-access full textSource: OpenAlex

  34. Efficacy and tolerability of eribulin mesylate in the treatment of anthracycline and taksan resistance to metastatic breast cancer. Single central experience

    Ortadoğu Tıp Dergisi, 2018

    DOI 10.21601/ortadogutipdergisi.409706 Open-access full textSource: OpenAlex

  35. Metastatik Pankreaas Kanserli Türk Hastalarda FOLFİRİNOX Rejiminin Etkinlik ve Tolerabilitesi

    Van Yüzüncü Yıl University Academic Data Management System, 2017

    Source: OpenAlex

  36. METASTATİK PANKREAS KANSERLİ TÜRK HASTALARDA FOLFİRİNOX REJİMİNİN ETKİNLİK VE TOLERABİLİTESİ.

    Çanakkale Onsekiz Mart University AVESIS, 2017

    Source: OpenAlex

  37. The impact of ramazan i’tikaf on immune system

    Malaysian Journal of Public Health Medicine, 2017

    DOI 10.37268/mjphm/vol.17/no.3/art.221 1 citation (OpenAlex) Open-access full textSource: ORCID

  38. EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.

    Journal of Clinical Oncology, 2017

    DOI 10.1200/jco.2017.35.15_suppl.e15028 Open-access full textSource: OpenAlex

  39. What are the differences between young (≤25 years) and adults (>25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.

    Journal of Clinical Oncology, 2015

    DOI 10.1200/jco.2015.33.15_suppl.e14657 Open-access full textSource: OpenAlex

  40. Gastric metastasis of triple negative invasive lobular carcinoma

    Rare Tumors, 2015

    DOI 10.4081/rt.2015.5764 PMID 26266010 13 citations (Europe PMC) Open-access full textSource: ORCID

  41. Prognostic factors for gemcitabinerefractory patients with advanced pancreatic cancer: A retrospective analysis of a multicentre study (Anatolian society of medical oncology)

    Wspolczesna Onkologia, 2015

    DOI 10.5114/wo.2014.43933 PMID 26034390 1 citation (Europe PMC) Open-access full textSource: ORCID

  42. Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer

    Tumor Biology, 2015

    DOI 10.1007/s13277-015-3066-2 PMID 25596702 8 citations (Europe PMC) Source: ORCID

  43. Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma

    Case Reports in Cardiology, 2015

    DOI 10.1155/2015/958756 PMID 26060585 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  44. Comparison of in-Hospital Cardiopulmonary Resuscitation Results Before and After the Introduction Code Blue

    Turkiye Klinikleri Journal of Anesthesiology Reanimation, 2015

    DOI 10.5336/anesthe.2014-42431 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  45. Metastatik meme kanserinde beyin metastazlarının erken veya geç saptanmasının ve diğer prognostik faktörlerin sağ kalıma etkisi var mı ?

    Çanakkale Onsekiz Mart University AVESIS, 2015

    Source: OpenAlex

  46. Pathologic and Clinical Characteristics of Elderly Patients With Breast Cancer: A Retrospective Analysis of a Multicenter Study (Anatolian Society of Medical Oncology)

    International Surgery, 2014

    DOI 10.9738/intsurg-d-13-00010 PMID 24444261 6 citations (Europe PMC) Open-access full textSource: OpenAlex

  47. Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology.

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e16094 2 citations (OpenAlex) Source: OpenAlex

  48. P0146 The prognostic role of XRCC1, ERCC1, ERCC2, and TP53 single nucleotide polymorphisms in resected non-small-cell lung cancer

    European Journal of Cancer, 2014

    DOI 10.1016/j.ejca.2014.03.190 Source: OpenAlex

  49. Relation of metastatic stage at the diagnosis of non-small cell lung cancer (NSCLC) to XRCC1 and TP53 single nucleotide polymorphisms (SNPs).

    Journal of Clinical Oncology, 2014

    DOI 10.1200/jco.2014.32.15_suppl.e19109 Source: OpenAlex

  50. Childhood, Adolescents, and Young Adults (≤25 y) Colorectal Cancer

    Journal of Pediatric Hematology/Oncology, 2013

    DOI 10.1097/mph.0b013e31827e7f20 PMID 23337551 22 citations (Europe PMC) Open-access full textSource: OpenAlex